In Brief: Acuson/Kaiser Permanente
This article was originally published in The Gray Sheet
Executive Summary
Acuson/Kaiser Permanente: Acuson to become two-year, sole-source provider of cardiac ultrasound systems for adult, pediatric, intraoperative and stress echocardiography applications to the 323-hospital health management organization under an Oct. 28 agreement. The deal calls for the HMO to purchase replacement and additional cardiac ultrasound units such as Acuson's Sequoia C256 and Aspen systems. The pact follows an August agreement making Acuson Kaiser's sole-source provider of radiology and vascular ultrasound systems...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.